WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H130576
CAS#: 2761321-26-8
Description: BRD4-BD1 inhibitor 16d is a novel BRD4-BD1-selective inhibitor. It shows significant selectivity for two bromodomains of BRD4, where the inhibition of BD1 (IC50 = 2.51 µM) was 20-times greater than that of BD2 (IC50 > 50 µM).
Hodoodo Cat#: H130576
Name: BRD4-BD1 inhibitor 16d
CAS#: 2761321-26-8
Chemical Formula: C20H15Br3N4O2
Exact Mass: 579.87
Molecular Weight: 583.080
Elemental Analysis: C, 41.20; H, 2.59; Br, 41.11; N, 9.61; O, 5.49
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: BRD4-BD1 In 16d, BRD4 BD1 inhibitor 16d, BRD4-BD1 In 16d, BRD4 BD1 In 16d
IUPAC/Chemical Name: 8-Bromo-1,7-bis(4-bromobenzyl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione
InChi Key: OPAIYDQJAQCNOX-UHFFFAOYSA-N
InChi Code: InChI=1S/C20H15Br3N4O2/c1-25-17-16(26(19(23)24-17)10-12-2-6-14(21)7-3-12)18(28)27(20(25)29)11-13-4-8-15(22)9-5-13/h2-9H,10-11H2,1H3
SMILES Code: O=C(N1CC2=CC=C(Br)C=C2)N(C)C3=C(N(CC4=CC=C(Br)C=C4)C(Br)=N3)C1=O
Appearance: To be determined
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 583.08 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1. Chang, Y., Zhang, J., Yang, S. et al. Design, synthesis, biological evaluation, and molecular docking of 1,7-dibenzyl-substituted theophylline derivatives as novel BRD4-BD1-selective inhibitors. Med Chem Res 30, 1453–1468 (2021). https://doi.org/10.1007/s00044-021-02737-2